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Abstract
Background: Cigarette smoking is a strong cardiovascular risk factor and endothelin (ET) receptors are related to coronary
artery diseases. The present study established an in vivo secondhand smoke (SHS) exposure model and investigated the
hypothesis that cigarette smoke induces ET receptor upregulation in rat coronary arteries and its possible underlying
mechanisms.
Methodology/Principal Findings: Rats were exposed to SHS for 200 min daily for 8 weeks. The coronary arteries were
isolated and examined. The vasoconstriction was studied by a sensitive myograph. The expression of mRNA and protein for
receptors was examined by real-time PCR, Western blot and immunofluorescence. Compared to fresh air exposure, SHS
increased contractile responses mediated by endothelin type A (ETA) and type B (ETB) receptors in coronary arteries. In
parallel, the expression of mRNA and protein for ETA and ETB receptors of smoke exposed rats were higher than that of
animals exposed to fresh air, suggesting that SHS upregulates ETA and ETB receptors in coronary arteries in vivo.
Immunofluorescence staining showed that the enhanced receptor expression was localized to the smooth muscle cells of
coronary arteries. The protein levels of phosphorylated (p)-Raf-1 and p-ERK1/2 in smoke exposed rats were significantly
higher than in control rats, demonstrating that SHS induces the activation of the Raf/ERK/MAPK pathway. Treatment with
Raf-1 inhibitor GW5074 suppressed SHS-induced enhanced contraction mediated by ETA receptors, and inhibited the
elevated mRNA and protein levels of ETA and ETB receptors caused by SHS. The results of correlation and regression analysis
showed that phosphorylation of Raf and ERK1/2 were independent determinants to affect protein expression of ETB and ETA
receptors.
Conclusions/Significance: Cigarette smoke upregulates ETB and ETA receptors in rat coronary artery, which is associated
with the activation of the Raf/ERK/MAPK pathway.
Citation: Cao L, Zhang Y, Cao Y-X, Edvinsson L, Xu C-B (2012) Cigarette Smoke Upregulates Rat Coronary Artery Endothelin Receptors In Vivo. PLoS ONE 7(3):
e33008. doi:10.1371/journal.pone.0033008
Editor: Rory Edward Morty, University of Giessen Lung Center, Germany
Received September 13, 2011; Accepted February 2, 2012; Published March 7, 2012
Copyright:  2012 Cao et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted
use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by the Swedish Research Council (grant no. 5958), the Flight Attendant Medical Research Institute, USA, and the National
Natural Science Foundation of China (30772566). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the
manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: Cang-Bao.Xu@med.lu.se
Introduction
Cigarette smoking is considered one of the most powerful risk
factors for the development of cardiovascular disease (CVD), such
as coronary artery disease (CAD), ischemic and congestive heart
failure [1]. Increasing evidences demonstrate that passive smoke
(secondhand smoke, SHS) contains relatively higher concentra-
tions of toxic gaseous components than mainstream smoke [2].
Smoking is strongly associated with the pathogenesis of CAD
which may be attributed to the promotion of atherosclerosis, the
triggering of coronary thrombosis, coronary artery spasm and
reduced capacity of the blood to deliver oxygen [3]. Although
cigarette smoking is an established risk factor for atherosclerosis,
the actual mediator of CAD associated with smoking is unknown.
The endothelin system plays an important role in CVD
pathogenesis. Endothelin-1 (ET-1) is one of the important
vasoactive peptide participating in the regulation of vascular
functions, such as controlling the basal coronary artery tone [4].
To exert its effects, ET-1 binds to transmembrane endothelin type
A (ETA) and type B (ETB) receptors to mediate vasomotor
responses [5] which can alter the diameter of the vessel lumen as
well as blood flow in the vasculature [6]. The ETA and ETB
receptors in the vascular smooth muscle cells (VSMC) are involved
in the atherosclerotic process by enhancing proliferation and
migration of the VSMC [7]. In addition, there are many
observations of ETB receptor upregulation in patients [8] and
experimental models [9] of atherosclerosis and ischemic heart
disease [10].
The ET receptor system has been shown to be involved in the
pathophysiological events that are associated with cigarette
smoking [11]. By using an in vitro model, we have shown that
dimethylsulfoxide-soluble smoke particles induce upregulation of
ET receptors in rat cerebral [12] and mesenteric [13] arteries.
Recently, a novel aspect of the vascular pathophysiology has been
revealed, namely the upregulation of vasoconstrictor receptors in
the smooth muscle of arteries [14]. There are differences in
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occur as a result in various diseases. As we know, receptor changes
in cerebral arteries are related to ischemic stroke [14]. Receptor
expression alterations in coronary arteries are associated with
CAD and/or atherosclerosis [8,10]. Likewise, the coronary artery
also possesses ET receptors [15]. Therefore, we hypothesize that
cigarette smoking or SHS upregulates coronary artery ET
receptors, which may be of considerable relevance to the
understanding of SHS-associated CAD and/or atherosclerosis.
The mitogen-activated protein kinases (MAPKs) are serine/
threonine-specific protein kinases that respond to extracellular
stimuli and regulate various cellular activities [16]. MAPKs consist
of three main signaling pathways: extracellular signal-regulated
protein kinase 1 and 2 (ERK1/2), c-Jun N-terminal kinase (JNK)
and p38 [17]. Raf-1 is the initial protein kinase in MAPK signal
transduction and takes turns to phosphorylate the subsequent
MAP kinase/ERK (MEK) 1/2 and ERK1/2 [18]. The MAPK
signaling pathways have been shown to be associated with the
process of receptor upregulation in human and rat vasculatures
[19,20]. Recent studies have demonstrated that the ETB and ETA
receptor upregulation can be attenuated by using a MEK/ERK
inhibitor [21], supporting that there is a tight correlation between
MEK/ERK pathway and ET receptor upregulation.
The present study established an in vivo SHS exposure model
and investigated the hypothesis that cigarette smoke induces ET
receptor upregulation in rat coronary arteries through activation
of the Raf/ERK/MAPK pathway.
Results
ET Receptor-Mediated Contractions
The left anterior descending (LAD) coronary artery segments
were examined. The contraction induced by K
+ was used as a
reference for the contractile capacity. SHS exposure in vivo did not
affect the ability of the smooth muscle to contract in response to
high K
+-solution in vitro (table 1). The mean value of the K
+
responses in fresh segments was 3.5060.22 mN (n=10) and in the
smoke exposed rat LAD ring segments it was 3.8060.34 mN
(n=9); there was no significant difference between the groups.
In control experiments on fresh coronary arteries, the selective
ETB receptor agonist sarafotoxin 6c (S6c) induced a slight
contraction with an Emax value of 9.361.1% (n=10) relative to
the K
+ responses. SHS exposure resulted in enhanced S6c-induced
contractile responses in coronary arteries (Fig. 1A). The concen-
tration-response curve for S6c gave an Emax of 24.463.1% (n=9,
P,0.01) and a pEC50 of 8.9060.22 (table 1), indicating that the
efficacy of the response increased after smoke exposure. Inhibition
of the Raf/ERK/MAPK pathway with GW5074 treatment did
not significantly influence the contraction induced by S6c (Fig. 1A)
and there was no statistical significance either in Emax or pEC50
values between the smoke and treatment groups (table 1).
ETA receptor-mediated vasoconstriction was examined after
desensitization of ETB receptor with S6c prior to adding ET-1 (a
combined ETA and ETB receptor agonist) [22]. Cumulative
administration of ET-1 induced potent contraction in fresh
coronary arteries (Fig. 1B), showing an Emax of 15364% and
pEC50 of 7.8260.03 (n=10, table 1). SHS exposure shifted the
concentration-response curve toward the left with an increased
pEC50 of 8.2960.05 (n=9, P,0.01, table 1). There was no
significant difference of the Emax values between smoke and fresh
air groups (table 1). After treatment with GW5074, ET-1-induced
concentration-contraction curve was shifted toward the right in a
parallel manner with a decreased pEC50 of 7.9460.06 (n=8,
P,0.01, table 1) returning to the similar level of fresh ones, as
compared to the smoke group.
mRNA Levels of Endothelin Receptors
The mRNA content of ETB and ETA receptors in coronary
arteries was examined by real-time PCR. Results showed that
following smoke exposure the mRNA level of coronary artery ETB
receptor relative to GAPDH was increased to 15269% (n=5)of
fresh air group (P,0.01, Fig. 2A). Similarly, ETA receptor mRNA
level was found significantly enhanced in coronary arteries from
smoke exposed rats (13268%, n=5) as compared to the fresh air
exposed ones (P,0.01, Fig. 2B). This is in concert with the findings
on isometric contraction.
In order to demonstrate the intracellular pathway involved, we
studied the inhibitory effects of Raf-1 inhibitor GW5074 on smoke
exposure. Results showed that GW5074 suppressed the increased
mRNA expression of both ETB and ETA receptors induced by
smoke exposure (Fig. 2A, B). The mRNA level declined to
11868% (ETB receptor, n=5, P,0.05) and 11065% (ETA
receptor, n=5, P,0.05), respectively, in comparison with the
group exposed to smoke only.
Protein Expression of Endothelin Receptors
The protein levels of ETB and ETA receptors in coronary
arteries were examined by Western blot. The results showed that
the protein level of ETB receptor relative to b-actin was 0.0460.01
(n=5) in fresh air exposed rats. In the smoke group, the ETB
receptor protein increased up to 0.3160.06 (n=5, P,0.01,
Fig. 3A). The expression of ETA receptor was exhibited in a
similar way. Result showed that the protein level of ETA receptor
Table 1. Contractile response property of coronary arteries induced by K
+, S6c and ET-1.
S6c ET-1
Group n K
+ (mN) Emax(% of K
+) pEC50 Emax(% of K
+) pEC50
Fresh air 10 3.560.22 9.361.1 9.1160.11 15364 7.8260.03
Smoke 9 3.860.34 24.463.1
** 8.9060.22 16769 8.2960.05
**
Smoke+GW5074 8 4.160.39 18.163.0 9.1060.17 16269 7.9460.06
##
The coronary arteries were isolated from rats exposed to fresh air, cigarette smoke and cigarette smoke plus GW5074 (0.5 mg/kg). Emax represents maximal contraction,
pEC50 represents the negative logarithm of the agonist concentration that produces 50% of the maximal contractile effect. Coronary artery contractile responses were
induced by K
+, S6c and ET-1. K
+-induced responses were expressed as absolute values of contraction (mN), and S6c and ET-1-elicited responses were expressed as
percentage of K
+-induced contraction. Statistical analysis was performed with unpaired student’s t-test with Welch’s correction.
**P,0.01 vs. fresh air group;
##P,0.01 vs. smoke group.
doi:10.1371/journal.pone.0033008.t001
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a markedly increase (0.6660.11, n=5, P,0.01) after smoke
exposure (Fig. 3B). These results agree with both functional and
mRNA studies shown above. Taken together, the data demon-
strated that SHS exposure induces ETB and ETA receptor
upregulation.
Western blotting was also performed in the smoke group treated
with Raf-1 inhibitor GW5074. There was a significant decline in
the protein level of the ETB receptor (0.1660.02, n=5,P,0.05) in
coronary arteries from rats exposed to SHS plus GW5074
treatment (Fig. 3A), compared to SHS exposure alone. However,
the protein level in treatment group remained elevated from the
fresh air group (P,0.05). For the ETA receptor, the protein level
was significantly decreased after inhibition of the Raf/ERK/
MAPK pathway (Fig. 3B). The protein level of ETA receptor
relative to b-actin was 0.2960.10 (n=5) following treatment with
GW5074, compared to 0.6660.11 (n=5, P,0.05) in the smoke
group. The Raf-1 blocker GW5074 inhibited the increased
receptor expression caused by smoke exposure, which supports
that Raf/ERK/MAPK pathway is activated by cigarette smoke
exposure.
The ETB and ETA receptor protein levels were visualized by a
fluorescence immunohistology method. There was a significant
increase in both ETB and ETA receptor protein levels in the
VSMC layer of SHS exposed rat coronary arteries, compared to
the arteries from fresh air groups (Fig. 4A, B). Treatment with Raf-
1 inhibitor GW5074 prevented the increase in expression of ETB
and ETA receptors in the VSMCs of coronary arteries (P,0.05,
Fig. 4A, B).
MAPK Signal Pathway Studies
The proteins of phosphorylated (p)-Raf-1, p-ERK1/2, p-p38
and p-JNK, and their total protein expressions were examined by
Western blotting in coronary arteries from rats exposed to fresh air
and cigarette smoke. The results showed that the total Raf-1 and
ERK1/2 proteins were at the same level in fresh air and smoke
group. However, the levels of p-Raf-1 and p-ERK1/2 proteins
relative to their own total protein in smoke exposed animals were
0.5360.10 (p-Raf-1) and 0.3560.07 (p-ERK1/2), respectively,
which were both higher than that found in the fresh air group of
Figure 2. The mRNA level of ETB and ETA receptors in rat
coronary arteries. The coronary arterial segments were isolated from
rats exposed to fresh air, cigarette smoke and cigarette smoke plus
GW5074. ETB (A) and ETA (B) receptor mRNA was relative to
housekeeping gene GAPDH and shown as percentage of fresh air
group by real-time PCR (n=5). Statistical analysis was performed using
one-way ANOVA with Dunnett’s post-test.
**P,0.01 vs. fresh air group,
#P,0.05 vs. smoke group.
doi:10.1371/journal.pone.0033008.g002
Figure 1. Concentration-contractile responses induced by S6c
and ET-1 in rat coronary arteries. The coronary arterial segments
were isolated from rats exposed to fresh air, cigarette smoke and
cigarette smoke plus GW5074. Contractions were induced by cumula-
tive application of S6c (A) or ET-1 (B). The contractile responses were
shown as percentage of K
+-induced contraction (n=8–10). Statistical
analysis was performed using two-way ANOVA with Bonferroni’s post-
test.
*P,0.05,
**P,0.01 vs. fresh air group,
#P,0.05,
##P,0.01 vs.
smoke group.
doi:10.1371/journal.pone.0033008.g001
Smoke Upregulates Coronary Endothelin Receptors
PLoS ONE | www.plosone.org 3 March 2012 | Volume 7 | Issue 3 | e330080.2360.09 (p-Raf-1; P,0.05, n=6, Fig. 5A) and 0.1060.05 (p-
ERK1/2; P,0.05, n=6, Fig. 5B), demonstrating that cigarette
smoke exposure activates Raf/ERK1/2 phosphorylation. In
contrast, the phosphorylation of p38 and JNK proteins were the
same in fresh air and smoke groups (data not shown).
Immunofluorescence staining demonstrated that there was an
increase in activated (phosphorylated) Raf-1 and ERK1/2 in the
VSMC layer of coronary arteries in smoke exposed rats as
compared with the ones from fresh air exposed rats (Fig. 5C). This
suggests that smoke exposure-induced receptor upregulation in
coronary artery occurs via activation of Raf/ERK1/2, but not
JNK or P38 pathways.
Relation of the receptor expression with Raf/ERK1/2
phosphorylation
Pearson’s correlation analysis showed that ETB/ETA receptor
protein expression measured by Western blot positively correlated
with Raf phosphorylation and ERK1/2 phosphorylation levels in
rat coronary artery in vivo. Moreover, the receptor immunofluo-
rescence intensity in SMC of coronary arteries was found to
positively correlate with phosphorylation of Raf and ERK1/2.
There were statistical significances in correlation coefficient (r)
values (P,0.05 or P,0.01) (table 2). Stepwise multiple regression
analysis was performed with receptor protein expression by
Western blot and fluorescence intensity as dependent variables,
and Raf phosphorylation and ERK1/2 phosphorylation as
independent variables. The regression coefficient, b showed
significant differences (P,0.05 or P,0.01) (table 2), indicating
that phosphorylation of Raf and ERK1/2 were independent
determinants that affected protein expression and immunofluo-
rescence staining of ETB and ETA receptors.
Discussion
Smoking is a significant independent risk factor for CVD and is
a leading cause of structural and functional alterations of the
cardiovascular system [23]. It has been demonstrated that
cigarette smoking is associated with vascular impairment which
includes injury to the vascular endothelium, producing superoxide
anions, reducing production and bioavailability of nitric oxide,
increasing production and release of endothelin, causing endothe-
lial dysfunction, atherosclerosis, which are all hallmarks of CAD
[23]. The present study has for the first time demonstrated that
SHS in vivo induces ET receptor upregulation in rat coronary
arteries, and this upregulation is involved in the activation of the
Raf/ERK/MAPK pathway. This may be a partial explanation of
mechanisms involved in cigarette smoke-associated CAD.
Increased arterial blood pressure, heart rate and ET-1 levels
were observed in smokers [24]. A previous study has already
reported a significant increase in plasma ET-1 in chronic cigarette
smoke exposed rats compared with non-smoking ones [11],
indicating that ET-1 is associated with cigarette smoking. If an
elevated ET-1 level is combined with increased number of ET
receptors, then the vasoconstrictor effect in the cardiovascular
system is magnified. If only the ET-1 level is increased but the
receptor number not changed, there would be less possibility to see
enhanced contractile responses in coronary arteries. If the receptor
amount is increased, there would be a stronger contraction
induced by ET-1. In other words, it is more crucial to examine the
receptor number change when we study the vascular contractile
property. A recent study showed that ETA and ETB receptor
antagonists attenuated vascular hyperreactivity in aortas and
carotid arteries of cigarette smoke exposed rats [11]. Tanus-Santos
et al. also found that blockade of the ETA receptor attenuated the
pressor effects of nicotine inhaled in cigarette exposed rats [25],
suggesting that ET receptor activation is associated with smoke-
induced vascular hyperreactivity and hence involved in the
pathological process of CVD. The coronary artery constriction/
tone with increased resistance is more prominent in chronic
smokers [26], which may contribute to the cardiovascular
consequences of cigarette smoking or SHS. In the present study,
we imitated the manner of SHS exposure in rats. The results
showed that the smoke exposure increased contractile responses
mediated by ETA and ETB receptors in coronary artery, but there
was a need to expose the animals for 8 weeks. The choice of the
time-point 8 weeks was based on a preceding study which revealed
that there was no significant alteration in receptor expression at 2
Figure 3. The protein expression of ETB and ETA receptors in
rat coronary arteries. The coronary arterial segments were isolated
from rats exposed to fresh air, cigarette smoke and cigarette smoke
plus GW5074. ETB (A) and ETA (B) receptor protein was shown relative to
b-actin by Western blot (n=5). Statistical analysis was performed using
one-way ANOVA with Dunnett’s post-test.
**P,0.01 vs. fresh air group,
#P,0.05 vs. smoke group,
$P,0.05 vs. fresh air group.
doi:10.1371/journal.pone.0033008.g003
Smoke Upregulates Coronary Endothelin Receptors
PLoS ONE | www.plosone.org 4 March 2012 | Volume 7 | Issue 3 | e33008or 4 weeks (data not shown). Since the contractile response reflects
respective receptor expression, the receptor-mediated vasocon-
striction should be in accordance with the receptor level.
Interestingly, we found parallel results of mRNA and protein
expressions of ETA and ETB receptors which are in agreement
with this view. The expression of mRNA and protein for both ETA
and ETB receptors in smoke exposed rats were higher than that in
animals exposed to fresh air. The results also demonstrate that the
increased ETA and ETB receptor expressions were primarily
localized to VSMC. Accordingly, our study reveals for the first
time that cigarette smoke upregulates contractile ETA and ETB
receptors of coronary artery in vivo.
ET receptor activation induces strong VSMC contraction and is
associated with aggravation of the progression of vessel wall
hypertrophy [20]. It is known that patients with atherosclerosis
have increased plasma levels of ET-1 [27]. Several studies have
revealed increased number of ETB receptors and stronger
contractile ETB receptor-mediated responses in coronary arteries
in atherosclerotic lesions [8], congestive heart failure [28] and
during organ culture of arteries [29]. There is a progressive
increase in ETB receptors in patients with suspected acute
coronary syndrome and with ischemic heart disease [30,31]. In
addition, both ETA and ETB receptor mRNA levels have in a
previous study been found to be significantly higher in coronary
arteries from patients with ischemic heart disease as compared to
healthy controls [10]. Collectively, this suggests that ETA and/or
ETB receptor upregulation occurs during CAD pathogenesis.
Therefore, blockage of ET receptors may offer a novel approach
for the treatment and may turn out to be beneficial in vascular
complications [32]. Many studies have reported that ETA and
ETB receptor antagonists effectively reduced cardiovascular
hypertrophy and decreased blood pressure in experimental
hypertension [33,34,35]. Taken together, upregulation of ET
receptors may be a key event in the development of CVD such as
CAD, ischemic heart disease and atherosclerosis.
We examined the histology of coronary arteries by hematoxylin
and eosin staining. The results demonstrate that there was no
difference in structure between the fresh air and the smoke groups
(data not shown). This suggests that our animal model of SHS
exposure did not affect coronary artery structure. Nevertheless, we
Figure 4. Immunofluorescence staining of ETB and ETA receptors in rat coronary arteries. (A) ETB and ETA receptor immunofluorescence in
coronary arteries isolated from rat exposed to fresh air, cigarette smoke and cigarette smoke plus GW5074. (B) Bar graphs showing fluorescence
intensity for ETB and ETA receptors. There was clear increase in ETB and ETA receptor protein levels in the smooth muscle cell layer of coronary arteries
from smoke exposed rats, as compared to the fresh ones. Treatment with GW5074 significantly suppressed the increased receptor expression. The
results were in arbitrary units of fluorescence intensity (%), a.u. Images were taken with a 406objective (n=5). Statistical analysis was performed
using one-way ANOVA with Dunnett’s post-test.
*P,0.05,
**P,0.01 vs. fresh air group,
#P,0.05 vs. smoke group.
doi:10.1371/journal.pone.0033008.g004
Smoke Upregulates Coronary Endothelin Receptors
PLoS ONE | www.plosone.org 5 March 2012 | Volume 7 | Issue 3 | e33008Figure 5. The effects of cigarette smoke on phosphorylation of Raf-1 and ERK1/2 in rat coronary arteries. The coronary arterial
segments were isolated from rats exposed to fresh air and cigarette smoke. The phosphorylated (p)-Raf-1 (A) and p-ERK1/2 (B) protein was shown
relative to total Raf-1 or ERK1/2 level using Western blot (n=6). Statistical analysis was performed using one-way ANOVA with Dunnett’s post-test.
*P,0.05 vs. fresh air group. (C) Immunofluorescence staining for phosphorylation of Raf-1 and ERK1/2. There was an increase in p-Raf-1 and p-ERK1/2
expression in the smooth muscle cell layer of coronary arteries from smoke exposed rats. Images were taken with a 406objective.
doi:10.1371/journal.pone.0033008.g005
Table 2. The r values of correlation analysis and b values of regression analysis between dependent variables, ET receptor protein
expression by Western blot and immunofluorescence staining and independent variables, the phosphorylated (p)-Raf-1, p-ERK1/2
in rat coronary arteries.
r values in correlation test b values in regression test
Dependent variables p-Raf p-ERK1/2 p-Raf p-ERK1/2
ETB receptor protein by Western blot 0.802
** 0.774
** 0.570
* 0.809
*
ETB receptor immunofluorescence 0.854
** 0.763
** 1.030
** 1.354
*
ETA receptor protein by Western blot 0.894
** 0.767
** 1.065
** 1.344
**
ETA receptor immunofluorescence 0.860
** 0.721
* 0.871
** 1.074
*
Correlation analysis was performed with Pearson’s correlation test and regression analysis was performed with a multiple regression test. The r value represents
correlation coefficient in correlation analysis (n=10) and b value represents regression coefficient in regression analysis (n=10).
*P,0.05,
**P,0.01.
doi:10.1371/journal.pone.0033008.t002
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SHS-exposed rats. The upregulated contractile receptors can lead
to enhanced coronary artery vasoconstriction to ET-1, which
further narrows the coronary artery lumen and reduces the blood
flow. This may aggravate and facilitate the pathological process of
SHS-induced coronary heart diseases. Therefore, we hypothesize
that there is a close relationship between ET receptors and SHS-
associated CVD.
The MAPK signal pathways are involved in a variety of
cellular programs including transcription of receptors. Activation
of MAPKs results in activation of transcription factors which
transcribe specific receptor genes in the nucleus, which are then
translated in the cytoplasm and exported to the cell membrane
[36]. In previous studies we have shown that the MEK/ERK
pathway is involved in the receptor upregulation, in particular
related to stroke [37]. Recently, we have revealed that cigarette
smoke extracts in vitro promote VSMC proliferation and enhance
contractile responses in vasculature via activation of ERK1/2
signaling [6]. In the present study, SHS exposure increased the
proportion of p-Raf-1 and p-ERK1/2 protein in coronary
arteries, indicating that the Raf/ERK/MAPK pathway may be
involved in the process of the ET receptor upregulation, but not
the p38 or the JNK pathways. Furthermore, our data of
correlation analysis in the present study showed significant
positive correlations between receptor (ETB and ETA)p r o t e i n
expression levels and Raf/ERK1/2 phosphorylation. On the
other hand, regression analysis showed that phosphorylation of
Raf and ERK1/2 were independent factors to impact protein
expression level and immunofluorescence intensity of ETB and
ETA receptors. These results suggest that the activation of the
Raf/ERK/MAPK pathway is closely linked to the receptor
expression in coronary arteries in vivo.
Raf-1 is a MAP kinase kinase kinase, which functions
downstream of the Ras family of protein kinases [18]. Activated
Raf-1 can phosphorylate MEK1 and MEK2, which in turn
activate ERK1 and ERK2. Downstream of Raf-1, activated
ERK1/2 plays an important role in the control of gene expression.
In the present study a Raf-1 inhibitor GW5074 was chosen to
further prove the involvement of Raf/ERK/MAPK pathway in
the upregulation. The specificity and efficacy of GW5074 for
inhibiting Raf-1 in vivo has been established in previous studies
[38]. The present results showed that GW5074 attenuated the
SHS-induced elevated coronary contraction mediated by ETA
receptors and the receptor mRNA and protein levels. In addition,
GW5074 decreased the smoke exposure-induced increase in
mRNA and protein levels of ETB receptors. This strongly suggests
that the SHS-induced upregulation of ETA and ETB receptors in
coronary artery is associated with the activation of the Raf/ERK/
MAPK signaling.
To conclude, cigarette smoke exposure upregulates ETA and
ETB receptors of rat coronary arteries, which is related to the
activation of the Raf/MEK/ERK pathway. This may provide a
new prospective on possible mechanisms involved in SHS-
associated CAD.
Materials and Methods
Animals
Experiments were performed on male Sprague-Dawley rats
(200–250 g) supplied by the Animal Center of Xi’an Jiaotong
University College of Medicine (Xi’an, China). Animals were
allowed free access to fresh food and water. All experimental
protocols were endorsed by the Animal Ethics Committee of Xi’an
Jiaotong University.
Cigarette Smoke Exposure Model
Thirty rats were randomly divided into 3 groups, 10 rats in
each group: (1) fresh air exposure; (2) smoke exposure; (3) smoke
exposure and treatment with GW5074 0.5 mg/kg. GW5074
was a gift from professor Yu-hai Tang (Science College of Xi’an
Jiaotong University, China) and its specificity has previously
been studied [38]. The rats were exposed to cigarette smoke
from commercially-available filter cigarettes (Marlboro, 1.0 mg
of nicotine and 12 mg of tar content) in a plastic chamber
(115650665 cm; 0.37 m
3) .T e nr a t sw e r ep u ti nt h ec h a m b e r
and each cigarette was lit from the cigarette end and freely
burning for 15 min, then let the cigarette smoke diffuse in the
whole chamber for another 25 min. Fresh air inhalation was
performed for at least 10 min after every 40 min of SHS
exposure [39]. For each smoke exposure, 2 cigarettes were lit
simultaneously. The rats were repeatedly exposed to the smoke
for total 10 cigarettes every day for up to 8 weeks. Total time of
smoke exposure was 5640 min=200 min/day. Gas chroma-
tography was used to determine the CO2 concentration inside
the chamber. It was 774685 ppm at the time point of burning
for 15 min and 611689 ppm when the smoke diffusing for
another 25 min, respectively. The rest of time animals were
exposed to fresh air. In fresh air group, rats were placed in
similar chambers and exposed to room air. For the treatment
group, GW5074 was administrated intraperitoneally to the
animals once every day for 8 weeks in addition to the same
condition of smoke exposure.
Coronary Artery Harvest
The rats were anesthetized with CO2 and decapitated to
prepare artery samples 24 h after the final exposure. The heart
was immediately removed and immersed into cold bicarbonate
buffer solution [40] from each rat. The LAD coronary arteries, left
circumflex arteries and right coronary arteries were isolated from
the heart. Some LAD arteries were cut into segments for
myograph function examination. Some LAD arteries were fixed
in 4% paraformaldehyde overnight for immunofluorescence
analysis. The other LAD arteries as well as circumflex arteries
and right coronary arteries were snap frozen at 280uC for real-
time PCR and Western blot studies.
Coronary Artery Contractile Studies
The in vitro contractility experiments were performed in the
Xi’an Jiaotong University, while the other experiments were done
in the Lund University. In the present study, wire myograph
(Danish Myo Technology A/S, Aarhus, Denmark) was used for
recording the vessels contractile properties. The LAD arteries
were cut into ring segments of approximately 1–2 mm in length
and then mounted on two thin wires (40 mm in diameter). The
set-up has been detailed described before [29]. The rings were
allowed to equilibrate for at least 1.5 h with an optimal resting
tension of 1.0 mN. Thereafter, the viability of the arterial
segments was determined by exposure to 63.5 mM K
+ buffer
solution.
Concentration-contraction responses were obtained by cumu-
lative administration of contractile receptor agonists S6c (Merck,
Darmstadt, Germany), and ET-1 (NeoMPS, Strasbourg, France).
The ETB receptor-mediated contractile response was obtained by
using the ETB receptor selective agonist S6c. When the
contraction reached the maximum, i.e. desensitization of ETB
receptor, ET-1 (both ETA and ETB receptor agonist) was then
administrated to induce a contraction response that was only
mediated by ETA receptors [40].
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Total RNA was extracted from the collected coronary arteries
using RNeasy Mini kit (Qiagen, Valencia, CA) with the instruction
of the supplier. The RNA concentration was measured and
recorded with an Eppendorf Biophotometer (Hamburg, Ger-
many). Reverse transcription of total RNA to cDNA was
performed using the TaqMan Reverse Transcription Reagents
(Applied Biosystems, Branchburg, USA) in a Perkin Elmer 2400
GeneAmp PCR system (Perkin Elmer, MA, USA). Real-time PCR
was carried out using the GeneAmp SYBRH Green kit (Applied
Biosystems) in a GeneAmp 7300 Sequence Detection System
(Applied Biosystems). The system automatically monitors the
binding of a fluorescent dye SYBRH Green to double-stranded
DNA during each cycle of PCR amplification. The real-time PCR
was prepared in 25 ml reaction volume and started at a
temperature of 50uC for 2 min; 95uC for 10 min and the following
40 thermal cycles with 95uC for 15s and 60uC for 1 min. The
dissociation curves were ran after the real-time PCR to identify the
specific PCR products. A blank without template was included in
all the experiments as negative controls. Specific primers for the
receptors were designed as follows: ETA receptor, forward: 59-
GTC GAG AGG TGG CAA AGA CC-39,E T A receptor, reverse:
59-ACA GGG CGA AGA TGA CAA CC-39;E T B receptor,
forward: 59-GAT ACG ACA ACT TCC GCT CCA-39,E T B
receptor, reverse: 59-GTC CAC GAT GAG GAC AAT GAG-39.
As an endogenous standard, the primers of glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) were designed as follows:
GAPDH, forward: 59-GTC CAC GAT GAG GAC AAT GAG-
39, GAPDH, reverse: 59-CGG CAT GTC AGA TCC ACA AC-
39. The comparative cycle threshold (CT) method was used for the
mRNA content analysis [41,42].
Western Blot
The coronary arteries were harvested as mentioned above, snap
frozen in liquid nitrogen. The arteries were homogenized in cell
extract denaturing buffer (BioSource, USA) with addition of a
phosphatase inhibitor cocktail and protease inhibitor cocktail
(Sigma, St. Louis, USA). The mixtures were then centrifuged at
12,0006ga t4 uC for 10 min and the supernatants were collected
as protein samples. Protein concentrations were measured by using
a protein assay reagent (Bio-Rad Laboratories, Hercules, CA) and
a Tecan Infinite M200 microplate reader. For western blotting,
protein samples were mixed with Laemmli Sample Buffer (Bio-
Rad Laboratories) and boiled for 5 min. Equal amount of protein
(40 mg) were loaded onto a 4–15% Ready Gel Precast Gels (Bio-
Rad Laboratories). A molecular weight marker was loaded onto
each gel for protein band identification. After gel eletrophoresis
the proteins were transferred to a nitrocellulose membrane (Bio-
Rad Laboratories). The membrane was then blocked in 5% non-
fat milk and incubated with the primary antibodies at appropriate
dilution at 4uC overnight. The antibodies used were shown as
follows: 1:200 rabbit anti-ETA receptor (sc-33535, Santa Cruz
Biotechology, CA, USA), 1:500 rabbit anti-ETB receptor
(ab65972, Abcam, Cambridge, UK), 1:1000 rabbit anti-phos-
pho-c-Raf (Ser338) (#9427, Cell Signaling Technology, Beverly,
CA), 1:2000 rabbit anti-phospho-ERK1/2 (#4370, Cell Signaling
Technology), 1:1000 rabbit anti-phospho-SAPK/JNK (#4668,
Cell Signaling Technology), 1:1000 rabbit anti-phospho-p38
(#4631, Cell Signaling Technology), 1:1000 mouse anti-b-actin
(#4970, Cell Signaling Technology) or 1:2000 mouse anti-ERK1/
2( #4696, Cell Signaling Technology). Then, membranes were
incubated with 1:2000 horseradish peroxidase-conjugated anti-
rabbit (#7074, Cell Signaling Technology) or anti-mouse (#7076,
Cell Signaling Technology) secondary antibodies for 1 h at room
temperature. Finally, membranes were developed and visualized
using a Fujifilm LAS-1000 Luminescent Image Analyzer (Fujifilm,
Stamford, USA) and the band intensity was quantified using
ImageJ software.
Immunofluorescence
The paraformaldehyde-fixed arteries were embedded in paraf-
fin and cut into 4-mm sections. After deparaffinization, the sections
were treated with 10 mM sodium citrate buffer, pH 6.0, in a
microwave oven for 10 min for antigen retrieval. Immunostaining
with rabbit polyclonal antibody ETA receptor (sc-33535, Santa
Cruz Biotechology) and ETB receptor (sc-33538, Santa Cruz
Biotechology) diluted 1:100, rabbit monoclonal phosphor-Raf-1
(Ser338) antibody (#9427, Cell Signaling Technology) and
phospho-ERK1/2 antibody (#4370, Cell Signaling Technology)
diluted 1:100 were performed. Goat anti-rabbit IgG conjugated to
fluorescence isothiocyanate (FITC, #10006588, Cayman Chem-
ical, Michigan, USA) diluted 1:100 was used as secondary
antibody. Then the slides were sealed with anti-fading mounting
medium. To identify the smooth muscle layer of the artery
segments, immunostaining with the primary antibody against rat
smooth muscle actin (sc-53015, Santa Cruz Biotechology) diluted
in 1:200, and the secondary antibody donkey anti-mouse IgG
(H+L) conjugated to Texas Red (#715-076-150, Jackson Im-
munoResearch) diluted in 1:200 were also performed. In the
control experiments, either the primary antibody or the secondary
antibody was omitted. Immunoreactivity was visualized with an
epifluorescence microscope (Nikon 80i, Tokyo, Japan) and
photographed using a digital camera (Nikon DS-2Mv).
Calculations and Statistics
All data are expressed as means 6 S.E.M. and n refers to the
number of rats. Contractile responses to agonists in each segment
were expressed as percentage of the K
+-induced contraction. Emax
values represent maximal contractile response elicited by agonists
and pEC50 values represent the negative logarithm of the agonist
concentration that produces 50% of the maximal contractile effect.
Unpaired Student’s t-test was applied to compare two sets of data.
One-way analysis of variance (ANOVA) with Dunnett’s post-test
was used for multiple comparisons. Two-way ANOVA with
Bonferroni’s post-test was performed to compare the two
corresponding data points at each concentration of the two
curves. Pearson’s correlation analysis was used to determine the
relationship between receptor protein expression and Raf/ERK1/
2 phosphorylation. Stepwise multiple regression analysis was
performed to define the factors of influencing the receptor protein
expression and fluorescence intensity in SMC of coronary arteries.
All calculations and statistical analysis were carried out using
Graph-Pad Prism 5.0 (GraphPad Software, La Jolla, USA).
Statistical significance was accepted when P,0.05.
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